Cargando…

Osteomalacia and renal failure due to Fanconi syndrome caused by long-term low-dose Adefovir Dipivoxil: a case report

BACKGROUND: Progressive bone pain and fracture and abnormal positron emission tomography combined with a computed tomography are main reasons for the oncologists suspecting bone tumor. During the patient’s medical treatment, the oncologists’ unfamiliarity with adverse reactions to anti-HBV drugs wer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiang, Qian, Liu, Zhiyan, Yu, Yanyan, Zhang, Hanxu, Xie, Qiufen, Mu, Guangyan, Zhang, Jianhua, Cen, Xinan, Cui, Yimin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275610/ https://www.ncbi.nlm.nih.gov/pubmed/32503675 http://dx.doi.org/10.1186/s40360-020-00421-6

Ejemplares similares

Clinical features of hypophosphatemic osteomalacia induced by long-term low-dose adefovir dipivoxil
por: Zhu, Sheng, et al.
Publicado: (2017)

Osteomalacia and Fanconi Syndrome Induced by Adefovir
por: Matsuoka, Natsumi, et al.
Publicado: (2019)

Low-dose adefovir dipivoxil–induced hypophosphatemia osteomalacia in five chronic hepatitis B virus–infected patients. Is low-dose adefovir dipivoxil–induced nephrotoxicity completely reversible?
por: Qian, Yan-Ying, et al.
Publicado: (2019)

Follow-Up of Adefovir Dipivoxil Induced Osteomalacia: Clinical Characteristics and Genetic Predictors
por: Zhao, Jiao, et al.
Publicado: (2021)

Fanconi syndrome induced by adefovir dipivoxil: a case report and clinical review
por: Song, Kaixin, et al.
Publicado: (2020)

Pathologic Femoral Neck Fracture Due to Fanconi Syndrome Induced by Adefovir Dipivoxil Therapy for Hepatitis B
por: Lee, Yoon-Suk, et al.
Publicado: (2016)

Pathological femoral fractures due to osteomalacia associated with adefovir dipivoxil treatment for hepatitis B: a case report
por: Tanaka, Motoyuki, et al.
Publicado: (2012)

Adefovir dipivoxil induced hypophosphatemic osteomalacia in chronic hepatitis B: a comparative study of Chinese and foreign case series
por: Chen, Nan, et al.
Publicado: (2018)

Nephrolithiasis and Osteomalacia associated with adefovir-induced Fanconi syndrome in a patient with hepatitis B
por: Lin, Jueying, et al.
Publicado: (2017)

De novo entecavir+adefovir dipivoxil+lamivudine triple-resistance mutations resulting from sequential therapy with adefovir dipivoxil, and lamivudine
por: Yang, Song, et al.
Publicado: (2016)

Fanconi syndrome due to prolonged use of low-dose adefovir
por: Wang, Xiao-Bing, et al.
Publicado: (2015)

A randomized, multi-central, controlled study of patients with hepatitis B e antigen-positive chronic hepatitis B treated by adefovir dipivoxil or adefovir dipivoxil plus bicyclol
por: Xie, Wen, et al.
Publicado: (2011)

Denosumab improves clinical manifestations of hypophosphatemic osteomalacia by adefovir-induced Fanconi syndrome: a case report
por: Kunii, Tomohisa, et al.
Publicado: (2019)

Effect of Hepatitis B Virus Genotypes on the Efficacy of Adefovir Dipivoxil Antiviral Therapy
por: Wen, Zhili, et al.
Publicado: (2014)

Adefovir dipivoxil inhibits APL progression through degradation of the oncoprotein PML-RARA
por: Gong, Xubo, et al.
Publicado: (2022)

Bone Histology of Two Cases with Osteomalacia Related to Low-dose Adefovir
por: Hiramatsu, Rikako, et al.
Publicado: (2016)

Hypophosphatemic Osteomalacia Associated with Adefovir-induced Fanconi Syndrome Initially Diagnosed as Diabetic Kidney Disease and Vitamin D Deficiency
por: Koda, Ryo, et al.
Publicado: (2018)

Effect of adefovir dipivoxil on T cell immune function in the treatment of chronic hepatitis B and hepatocirrhosis
por: Tian, Liting, et al.
Publicado: (2016)

Hemoclot Thrombin Inhibitor Assay and Expected Peak-Trough Levels of Dabigatran: A Multicenter Study
por: Liu, Zhiyan, et al.
Publicado: (2022)

Deep Sequencing Analysis of HBV Genotype Shift and Correlation with Antiviral Efficiency during Adefovir Dipivoxil Therapy
por: Wang, Yuwei, et al.
Publicado: (2015)

Meta-analysis: Adefovir dipivoxil in combination with lamivudine in patients with lamivudine-resistant hepatitis B virus
por: Chen, En-Qiang, et al.
Publicado: (2009)

Evolution of entecavir-resistant hepatitis B virus during entecavir and adefovir dipivoxil combination therapy
por: WANG, YANG, et al.
Publicado: (2016)

Switching Lamivudine with Adefovir Dipivoxil Combination Therapy to Entecavir Monotherapy Provides Better Viral Suppression and Kidney Safety
por: Lian, Jiang-Shan, et al.
Publicado: (2019)

Relationship between nephrotoxicity and long-term adefovir dipivoxil therapy for chronic hepatitis B: A meta-analysis
por: Luo, Qing, et al.
Publicado: (2016)

Factors Predicting the Efficacy of Adefovir Dipivoxil on Treatment-Naïve Chronic Hepatitis B Patients at 48 Weeks
por: Wang, Li-Chun, et al.
Publicado: (2011)

Cost-effectiveness analysis of lamivudine, telbivudine, and entecavir in treatment of chronic hepatitis B with adefovir dipivoxil resistance
por: Wang, Guiliang, et al.
Publicado: (2015)

Comparison of adefovir dipivoxil and pegylated interferon alpha-2a treatment in chronic hepatitis B patients
por: Korkmaz, Pinar, et al.
Publicado: (2014)

Screening of FDA-Approved Drug Library Identifies Adefovir Dipivoxil as Highly Potent Inhibitor of T Cell Proliferation
por: Voss, Linda, et al.
Publicado: (2021)

Kushenin Combined with Adefovir Dipivoxil or Entecavir for Chronic Hepatitis B: A Systematic Review and Meta-Analysis
por: Liao, Qingying, et al.
Publicado: (2021)

Adefovir Dipivoxil as a Therapeutic Candidate for Medullary Thyroid Carcinoma: Targeting RET and STAT3 Proto-Oncogenes
por: Alqahtani, Tariq, et al.
Publicado: (2023)

Sjögren’s Syndrome Associated with Fanconi’s Syndrome and Osteomalacia
por: Gutierrez, Jorge O., et al.
Publicado: (2018)

Osteomalacia, renal Fanconi syndrome, and bone tumor
por: Gou, Manting, et al.
Publicado: (2018)

Effect of Entecavir Combined with Adefovir Dipivoxil on Clinical Efficacy and TNF-α and IL-6 Levels in Patients with Hepatitis B Cirrhosis
por: Yu, Yonghuan, et al.
Publicado: (2021)

The different effects of adefovir dipivoxil and telbivudine on the prognosis of hepatitis b virus-related hepatocellular carcinoma patients after curative resection
por: He, Linye, et al.
Publicado: (2019)

Nephrogenic hypophosphatemic osteomalacia during adefovir monotherapy for chronic hepatitis B monoinfection
por: Xu, Yaowen, et al.
Publicado: (2013)

Adefovir Dipivoxil Alone or in Combination with Ongoing Lamivudine in Patients with Decompensated Liver Disease and Lamivudine-resistant Hepatitis B Virus
por: Kim, Kang Mo, et al.
Publicado: (2005)

Initial combination anti-viral therapy with lamivudine and adefovir dipivoxil decreases short-term fatality rate of hepatitis-B-virus-related acute-on-chronic liver failure
por: Yang, Jiahong, et al.
Publicado: (2015)

Detection of rtN236T mutation associated with adefovir dipivoxil resistance in Hepatitis B infected patients with YMDD mutations in Tehran
por: Monavari, Seyed Hamidreza, et al.
Publicado: (2013)

Telbivudine and adefovir dipivoxil combination therapy improves renal function in patients with chronic hepatitis B: A STROBE-compliant article
por: Xu, Yong, et al.
Publicado: (2018)

A Simple and Specific Stability- Indicating RP-HPLC Method for Routine Assay of Adefovir Dipivoxil in Bulk and Tablet Dosage Form
por: Darsazan, Bahar, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_m1i92pp6omqnmhfijp59ilqvuj